Italy approves J&J vaccine, recommends it for over 60s

Credit score: Unsplash/CC0 Public Area

Italy on Tuesday declared the Johnson & Johnson coronavirus vaccine to be “secure” and stated it will prioritise its use for folks over 60.

The announcement got here hours after the Ecu Drugs Company (EMA) stated blood clots will have to be indexed as a “very uncommon” facet impact of the vaccine.

Within the gentle of that ruling, the US-made jab will have to be thought to be “unquestionably secure,” Italian well being government stated in a commentary.

It “will have to be preferentially administered to folks over 60 years outdated” and the ones specifically in peril from the virus, they added.

The similar tips have been prior to now issued in Italy for the Anglo-Swedish AstraZeneca jab, which has additionally been related to very uncommon circumstances of blood clotting.

One at a time, Italy’s coronavirus disaster commissioner stated a primary consignment of 184,000 J&J doses can be dispensed around the nation beginning Wednesday.

The J&J vaccine is observed as more uncomplicated to manage and delivery than a few of its competitors, as it calls for only one dose and will also be saved at hotter temperatures.

However its advent in Europe was once suspended ultimate week after US well being regulators stated the shot will have to be paused over blood clot fears.

Italy and different EU international locations are prepared to use it to boost up their gradual vaccination campaigns and convey nearer a go back to a few degree of normality in folks’s lives.

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2021 AFP

Italy approves J&J vaccine, recommends it for over 60s (2021, April 20)
retrieved 20 April 2021

This record is topic to copyright. With the exception of any honest dealing for the aim of personal find out about or analysis, no
phase could also be reproduced with out the written permission. The content material is supplied for info functions simplest.

Leave a Reply

Your email address will not be published. Required fields are marked *